Scienture Holdings, Inc. — Form 8-K
Filed October 7, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Scienture Holdings (NASDAQ: SCNX), a $10.2M market-cap pharmaceutical company, executed a 1-for-25 reverse stock split effective October 5, 2026. Outstanding shares reduced from 41,064,146 to approximately 1,642,565 shares. The stated purpose is to maintain Nasdaq continued listing compliance (minimum bid price requirement) and increase available shares for future issuance. No fractional shares issued; cash paid in lieu. Par value and authorized shares unchanged.
Why this rating
Reverse split signals Nasdaq compliance distress and dilution risk; material for tiny-cap but common distress signal. Negative price pressure typical post-announcement.
Price action (we called it negative)
before filing · preread $3.60 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.